Search Results for: Cybin

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, today announced continued augmentation of its Special Advisory Committee with the addition of key individuals experienced in highly regulated … Continue reading “QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Expands Special Advisory Committee with Appointment of University of Toronto Clinical Advisor, Pharmacognosist”

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a health and wellness company specializing in the formulation of medicinal mushrooms health products and novel delivery platforms for the pharmaceutical and nutraceutical industries, today announced its entry into a definitive agreement to acquire Tassili Life Sciences Corp. Per the update, the move will expand the Company’s … Continue reading “QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Enters Definitive Agreement to Acquire Tassili Life Sciences Corp.”

Champignon Brands (CSE: SHRM), a wellness company specializing in medicinal mushroom and mushroom-infused products, today announced the expansion of its vertically integrated, alternative medicine product portfolio with the addition of new proprietary intellectual property (“IP”). SHRM recently entered into a definitive agreement, signed March 18, 2020, to acquire Novo Formulations Ltd. (“Novoformulations”), a specialty biotechnology … Continue reading “QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) Inks Agreement to Acquire Novo Formulations, Broadens Alternative Medicine Portfolio”